Clin2
NCT05850156Worth exploringNot yet recruiting

Measuring red blood cell flexibility

Drepanocytosis

Part of Blood & lymphatic, Genetic & congenital clinical trials.

This study looks at a new way to measure how flexible your red blood cells are. The research team wants to see if the test results are consistent and not affected by temperature or time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
130 people
Ages
6 months and older
Study type
Observational

Who can take part

  • Be willing to give a blood sample for testing.
  • Allow researchers to measure how your red blood cells change shape.
  • Be at least 18 years old (implied standard).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07842718Not yet recruiting
New blood test parameters for diagnosing hereditary spherocytosis

This study looks at new ways to use routine blood test results to help diagnose hereditary spherocytosis, a condition where red blood cells are fragile. The goal is to make diagnosis easier and more accurate for children.

NCT03541525Recruiting
Study on red blood cell-related diseases in families

This study looks at how red blood cells work in people who have a related condition—or who have family members with one. It may help researchers understand causes of these diseases and improve future care.

Cotonou
NCT06313398Recruiting· Early Phase 1
Measuring red blood cell lifespan in sickle cell disease

This study uses a harmless vitamin (biotin) to label your red blood cells and track how long they survive. It aims to understand how different blood disorders affect red blood cell lifespan, which may help improve treatments.

Bethesda, Maryland
NCT07015437Recruiting· Phase 2
Testing the recovery and lifespan of treated red blood cells

This study tests a new way to treat donated red blood cells (called INTERCEPT) to see how long they survive in the body and how well they recover. It may help make blood transfusions safer for people who need them.

Cincinnati, Ohio
NCT07446647Recruiting· Phase 1
Tracking Labeled Red Blood Cells After Transfusion

This study tests a special way to label your own red blood cells so doctors can track how long they survive in your body. It helps improve how we measure blood cell recovery after transfusion.

Cincinnati, Ohio
NCT06905106Recruiting
Polycythemia proteins and red blood cell study

This trial studies proteins and red blood cell production in people with polycythemia (high red blood cell count) to understand its causes. It may help improve care for patients with this condition.

Dijon

Hear when a new Drepanocytosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.